Ethyl6-bromo-7-methyl-pyrazolo[1,5-a]pyridine-3-carboxylate, 98%, 1g

2-Amino-2-oxazoline Hydrochloride>98.0%(T)25g

(1R,3S)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate compound with (1S,3R)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate, 98%, 1g

(2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethyl)amine dihydrochloride, 95.0%, 250mg

2-Chloro-N,N-dicyclohexyl-acetamide, 99%, 500mg

p-(Octyloxyphenyl)phenyliodonium hexafluor antimonate, 25g

(3-Bromopropyl)phosphonic acid, 98%, 25g

1-(3-Bromopropyl)-4-nitrobenzene, 97%, 1g

3-Bromopyridine-4-methanol, 97.0%, 10g

Bergenin, 99.63%, 50mg

1,2-O-Isopropylidene-alpha-D-glucofuranose, 95.0%, 100g

5-methylsalicylic acid, min. 98%, for synthesis, 5 g, plastic packaging.

8-cyclopentyl-8-azabicyclo[3.2.1]octan-3-one, 95.0%, 5g